Ten years of serological surveillance in England and Wales: methods, results, implications and action.
about
The role of seroepidemiology in the comprehensive surveillance of vaccine-preventable diseasesSeroepidemiology: an underused tool for designing and monitoring vaccination programmes in low- and middle-income countriesUse of Pathogen-Specific Antibody Biomarkers to Estimate Waterborne Infections in Population-Based Settings.Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting.Standardization of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and Australia.C. trachomatis Pgp3 antibody prevalence in young women in England, 1993-2010The changing seroepidemiology of enterovirus 71 infection among children and adolescents in SingaporeSeroprevalence of serum bactericidal antibodies against group W135 and Y meningococci in England in 2009Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in England.HPV Serology Testing Confirms High HPV Immunisation Coverage in England.Epidemiology of Lyme Disease, Nova Scotia, Canada, 2002-2013Prevalence of serum bactericidal antibody to serogroup C Neisseria meningitidis in England a decade after vaccine introductionAge-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vaccPrevalence of human papillomavirus antibodies in young female subjects in EnglandSeroprevalence of antibodies against serogroup C meningococci in England in the postvaccination era.Lack of serologic evidence of Neospora caninum in humans, EnglandThe role of simple mathematical models in malaria elimination strategy designTrends in Haemophilus influenzae type b infections in adults in England and Wales: surveillance study.The immunogenicity and safety of a Hib-MenAC vaccine: a non-inferiority randomized, observer-blind trial in infants aged 3-5 months.Has the UK government lost the battle over MMR?Dynamic epidemic model for influenza with clinical complications.Seroprevalence of hepatitis B virus infection among children and adolescents in Singapore, 2008-2010.Markers of hepatitis B virus infection and immunity in Victoria, Australia, 1995 to 2005.Seroepidemiology of mumps in Europe (1996-2008): why do outbreaks occur in highly vaccinated populations?The burden of infection with cytomegalovirus in England and Wales: how many women are infected in pregnancy?The burden of parvovirus B19 infection in women of childbearing age in England and WalesInterpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century
P2860
Q26824389-27B2A4DE-AAB6-4687-8E0B-CEF22B889AC0Q28078813-F8004737-6857-4DB7-A6DD-5864E72CAC4BQ30249278-3C77A491-FABB-48F0-9445-78339D075A5DQ30416214-AEA0932F-A039-4A04-BDF4-145821E8A809Q31107510-3A42949C-2FE0-4DA6-B3FA-906F6BAD180EQ31132117-E27F565A-78CC-44CE-A17C-FFE531F883F8Q34046385-A68FBB6C-AD8C-4BCC-9B63-DF2DD034086AQ35739057-32CB6CCA-1291-4081-8628-C6D4E9639B37Q35946870-F8377651-922C-421E-862E-568C73D961B8Q35950913-EAE2D7FA-2BFD-4808-B705-9B35736280DAQ36121502-2664A22A-6D98-4D14-9E5A-E95FE0644940Q36154716-03DF24E6-F199-4034-B5C2-B542C46A278CQ36313578-E98B6738-9D11-4B2F-942F-14933A0E6903Q36611335-2B1E1721-363A-4F09-92F1-B6ED74EA9F87Q36974336-3E011C32-C5BD-48F6-9FE9-70432A68661EQ37009294-80FAD383-2138-46B6-A85F-4D0DFE24A589Q37368679-48BF98CD-3DF9-4282-818F-1F262B529FEDQ37525000-BFDB286F-8781-4700-A89A-3930E4369DF0Q40300059-B5357490-1FE0-42B5-BA75-F08506EC1439Q42958491-E5F569A4-0B1B-4421-89C4-F02C6BEBD112Q43173004-10E3D9E2-A48D-41E3-BAC9-26F09553B862Q45022308-2B66D7BD-9AC5-4C1C-AED6-8DA352B3B4DEQ45372582-EF4A0017-8762-4777-B299-13EB8B63042FQ47636789-4D37E0B5-780E-40F6-A3DE-CCF3EC1BA28CQ51122558-78872788-4753-40FF-8B68-32A13FF40232Q57385763-8D3A8CDC-DFB1-4D96-BB05-C077A71795D2Q57385765-CF18E28B-7691-430C-8202-0629E759690E
P2860
Ten years of serological surveillance in England and Wales: methods, results, implications and action.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Ten years of serological surve ...... ults, implications and action.
@en
Ten years of serological surve ...... ults, implications and action.
@nl
type
label
Ten years of serological surve ...... ults, implications and action.
@en
Ten years of serological surve ...... ults, implications and action.
@nl
prefLabel
Ten years of serological surve ...... ults, implications and action.
@en
Ten years of serological surve ...... ults, implications and action.
@nl
P2093
P2860
P356
P1476
Ten years of serological surve ...... ults, implications and action.
@en
P2093
P2860
P304
P356
10.1093/IJE/29.2.362
P577
2000-04-01T00:00:00Z